BAFHX
Price
$18.53
Change
+$0.08 (+0.43%)
Updated
Sep 11 closing price
Net Assets
671.76M
VEUSX
Price
$112.47
Change
+$0.73 (+0.65%)
Updated
Sep 11 closing price
Net Assets
39.06B
Interact to see
Advertisement

BAFHX vs VEUSX

BAFHX vs VEUSX Comparison Chart in %
View a ticker or compare two or three
VS
BAFHX vs. VEUSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFHX is a StrongBuy and VEUSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEUSX has more cash in the bank: 39.1B vs. BAFHX (672M). VEUSX pays higher dividends than BAFHX: VEUSX (2.79) vs BAFHX (1.32). BAFHX was incepted earlier than VEUSX: BAFHX (13 years) vs VEUSX (25 years). BAFHX (1.05) is less costly to investors than VEUSX (0.08). BAFHX is a more actively managed with annual turnover of: 47.00 vs. VEUSX (5.00). VEUSX has a lower initial minimum investment than BAFHX: VEUSX (3000) vs BAFHX (1000000). VEUSX annual gain was more profitable for investors over the last year : 12.76 vs. BAFHX (-0.83). BAFHX return over 5 years is better than : 44.80 vs. VEUSX (31.12).
BAFHXVEUSXBAFHX / VEUSX
Total Expense Ratio1.050.081,313%
Annual Report Gross Expense Ratio1.050.081,313%
Fund Existence13 years25 years-
Gain YTD3.0157.23642%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets672M39.1B2%
Annual Yield % from dividends1.322.7948%
Returns for 1 year-0.8312.76-6%
Returns for 3 years66.2150.61131%
Returns for 5 years44.8031.12144%
Returns for 10 years98.3991.56107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGIEX35.91N/A
N/A
Putnam Focused Equity C
ITHAX47.52N/A
N/A
Hartford Capital Appreciation A
IVRTX30.94N/A
N/A
VY® Columbia Real Estate S2
JOEMX17.82N/A
N/A
JOHCM Emerging Markets Opps Instl
EEMEX12.73N/A
N/A
MFS Emerging Markets Equity Research R2